Literature DB >> 15053953

Assessment of a small molecule melanocortin-4 receptor-specific agonist on energy homeostasis.

David Cepoi1, Teresa Phillips, Mary Cismowski, Val S Goodfellow, Nick Ling, Roger D Cone, Wei Fan.   

Abstract

The central melanocortin system has been demonstrated to play an important role in regulating different aspects of energy homeostasis. Understanding the specific contributions of MC3 and MC4 receptors, however, requires specific agonists and antagonists for each of the predominant forms of brain melanocortin receptors, MC3-R and MC4-R. We report here the characterization of a small peptide mimetic MC4-R-specific agonist that possesses both high affinity (K(i)=11.3 nM) and potency (EC(50)=1.62 nM) in vitro and is capable of inhibiting feeding behavior in mice when administered intracerebroventricularly (i.c.v.). Depending on the paradigm, acute (1 h following an overnight fast) or long-term (greater than 6 h under normal nocturnal feeding conditions) feeding inhibition was observed following icv injection. No effect on long-term feeding inhibition was observed with this compound in MC4-R knockout mice, and central administration of this compound had no effect on either metabolic rate or insulin release.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15053953     DOI: 10.1016/j.brainres.2003.10.041

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  4 in total

1.  Melanocortin 4 receptor signals at the neuronal primary cilium to control food intake and body weight.

Authors:  Yi Wang; Adelaide Bernard; Fanny Comblain; Xinyu Yue; Christophe Paillart; Sumei Zhang; Jeremy F Reiter; Christian Vaisse
Journal:  J Clin Invest       Date:  2021-05-03       Impact factor: 14.808

Review 2.  The melanocortin-4 receptor as target for obesity treatment: a systematic review of emerging pharmacological therapeutic options.

Authors:  L Fani; S Bak; P Delhanty; E F C van Rossum; E L T van den Akker
Journal:  Int J Obes (Lond)       Date:  2013-06-18       Impact factor: 5.095

3.  Disruption of Gpr45 causes reduced hypothalamic POMC expression and obesity.

Authors:  Jing Cui; Yi Ding; Shu Chen; Xiaoqiang Zhu; Yichen Wu; Mingliang Zhang; Yaxin Zhao; Tong-Ruei R Li; Ling V Sun; Shimin Zhao; Yuan Zhuang; Weiping Jia; Lei Xue; Min Han; Tian Xu; Xiaohui Wu
Journal:  J Clin Invest       Date:  2016-08-08       Impact factor: 14.808

4.  Chronic HO-1 induction with cobalt protoporphyrin (CoPP) treatment increases oxygen consumption, activity, heat production and lowers body weight in obese melanocortin-4 receptor-deficient mice.

Authors:  E Csongradi; J M Docarmo; J H Dubinion; T Vera; D E Stec
Journal:  Int J Obes (Lond)       Date:  2011-04-05       Impact factor: 5.095

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.